Anthrasil receives FDA approval for the treatment of inhalational anthrax

March 25, 2015 4:02 PM

19 0

Posted by Staff on March 25, 2015 //

The U.S. Food and Drug Administration yesterday approved Anthrasil, Anthrax Immune Globulin Intravenous (Human), to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs.

Read more

To category page